HLUBF Stock Financial Analysis - H. Lundbeck A/S (OTCPK) Stock

Overview

H. Lundbeck A/S is a global pharmaceutical company headquartered in Denmark, primarily engaged in the development and marketing of therapies for neurological and psychiatric disorders. A key player in the pharmaceutical industry, Lundbeck focuses on innovative treatments for conditions such as depression, schizophrenia, Parkinson's and Alzheimer's diseases. The company is deeply involved in the research and development of new pharmaceuticals aimed at addressing unmet needs in the management of these debilitating conditions. Through its commitment to neuroscience research, Lundbeck collaborates with partners worldwide to advance the understanding of the brain and pioneer breakthrough therapies, which remain central to its strategic initiatives and operational concentration.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for H. Lundbeck A/S as of June 30, 2025 is 23,521.00 MM.
The operating income for H. Lundbeck A/S as of June 30, 2025 is 5,374.00 MM.
The net income for H. Lundbeck A/S as of June 30, 2025 is 3,485.00 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	23,521.00	5,374.00	3,485.00
2025-03-31	22,951.00	4,807.00	3,289.00
2024-12-31	22,004.00	4,387.00	3,143.00
2024-09-30	21,441.00	3,536.00	2,687.00
2024-06-30	20,671.00	3,785.00	2,586.00
2024-03-31	20,156.00	3,636.00	2,416.00
2023-12-31	19,912.00	3,591.00	2,290.00
2023-09-30	19,614.00	3,430.00	2,467.00
2023-06-30	19,381.00	3,491.00	2,479.00
2023-03-31	18,918.00	3,210.00	2,384.00
2022-12-31	18,246.00	2,852.00	1,916.00
2022-09-30	17,619.00	2,640.00	1,603.00
2022-06-30	16,913.00	2,214.00	1,236.00
2022-03-31	16,398.00	2,236.00	1,109.00
2021-12-31	16,299.00	2,243.00	1,318.00
2021-09-30	16,521.00	2,380.00	1,873.00
2021-06-30	16,971.00	2,594.00	1,965.00
2021-03-31	17,381.00	3,477.00	2,110.00
2020-12-31	17,672.00	2,888.00	1,581.00
2020-09-30	17,818.00	2,807.00	904.00
2020-06-30
2020-03-31

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31	3.17	3.17
2024-09-30	2.71	2.71
2024-06-30	2.61	2.61
2024-03-31	2.44	2.43
2023-12-31	2.31	2.31
2023-09-30	2.49	2.48
2023-06-30	2.50	2.50
2023-03-31	2.40	2.41
2022-12-31	1.93	1.93
2022-09-30	1.61	1.62
2022-06-30	1.24	1.24
2022-03-31	1.12	1.11
2021-12-31	1.33	1.33
2021-09-30	1.89	1.89
2021-06-30	1.98	1.98
2021-03-31	2.12	2.13
2020-12-31	1.59	1.59
2020-09-30	0.91	0.91
2020-06-30	1.25	1.25
2020-03-31	1.52	1.52

Cash Flow: Operations, Investing, Financing

The cash from operating activities for H. Lundbeck A/S as of June 30, 2025 is 3,409.00 MM.
The cash from investing activities for H. Lundbeck A/S as of June 30, 2025 is -15,279.00 MM.
The cash from financing activities for H. Lundbeck A/S as of June 30, 2025 is 8,408.00 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	3,409.00	-15,279.00	8,408.00
2025-03-31	2,997.00	-15,303.00	9,909.00
2024-12-31	3,326.00	-15,286.00	11,629.00
2024-09-30	5,421.00	-482.00	-829.00
2024-06-30	4,609.00	-478.00	-1,619.00
2024-03-31	4,663.00	-515.00	-1,890.00
2023-12-31	4,080.00	-498.00	-2,085.00
2023-09-30	4,426.00	-894.00	-2,620.00
2023-06-30	4,457.00	-930.00	-2,117.00
2023-03-31	4,102.00	-806.00	-2,011.00
2022-12-31	3,519.00	-1,892.00	-387.00
2022-09-30	2,615.00	-1,638.00	-172.00
2022-06-30	2,313.00	-1,643.00	-133.00
2022-03-31	1,959.00	-1,689.00	-364.00
2021-12-31	2,272.00	-610.00	-3,336.00
2021-09-30	2,949.00	-543.00	-3,610.00
2021-06-30	2,912.00	-545.00	-3,890.00
2021-03-31	3,757.00	-483.00	-3,861.00
2020-12-31	3,837.00	-467.00	-2,394.00
2020-09-30	3,171.00	-7,613.00	5,218.00
2020-06-30
2020-03-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Management Effectiveness

The roa for H. Lundbeck A/S as of June 30, 2025 is 0.08.
The roe for H. Lundbeck A/S as of June 30, 2025 is 0.14.
The roic for H. Lundbeck A/S as of June 30, 2025 is 0.08.
The croic for H. Lundbeck A/S as of June 30, 2025 is -0.06.
The ocroic for H. Lundbeck A/S as of June 30, 2025 is 0.08.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.08	0.14	0.08	-0.06	0.08
2025-03-31	0.08	0.14	0.08	-0.01	0.08
2024-12-31	0.07	0.12	0.10	0.15	0.19
2024-09-30	0.07	0.12	0.09	0.09	0.17
2024-06-30		0.12
2024-03-31		0.11
2023-12-31			0.11	0.04
2023-09-30			0.11	0.06
2023-06-30		0.13
2023-03-31		0.13
2022-12-31		0.00
2022-09-30		0.00
2022-06-30		0.00	0.00
2022-03-31	0.03	0.06	0.04	-0.00	0.08
2021-12-31	0.04	0.08	0.06	-0.07	0.10
2021-09-30	0.05		0.31	-0.20	0.49
2021-06-30	0.06		0.08	-0.07	0.12
2021-03-31	0.06	0.15	0.09	-0.03	0.16
2020-12-31	0.04	0.11	0.06	0.04	0.15
2020-09-30	0.04	0.07	0.04	0.03	0.13
2020-06-30	0.08	0.13	0.07	0.06	0.13
2020-03-31	0.09	0.15	0.08	0.01	0.08

Gross Margins

The gross margin for H. Lundbeck A/S as of June 30, 2025 is 0.81.
The net margin for H. Lundbeck A/S as of June 30, 2025 is 0.14.
The operating margin for H. Lundbeck A/S as of June 30, 2025 is 0.21.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.81	0.14	0.21
2025-03-31	0.81	0.14	0.20
2024-12-31	0.80	0.13	0.16
2024-09-30	0.79	0.13	0.17
2024-06-30
2024-03-31
2023-12-31
2023-09-30		0.13	0.17
2023-06-30		0.13	0.17
2023-03-31		0.13	0.16
2022-12-31
2022-09-30		0.00	0.00
2022-06-30		0.00	0.00
2022-03-31	0.79	0.07	0.14
2021-12-31
2021-09-30
2021-06-30	0.76	0.12	0.16
2021-03-31	0.76	0.12	0.20
2020-12-31	0.77	0.09	0.17
2020-09-30	0.76	0.05	0.17
2020-06-30	0.80	0.10	0.22
2020-03-31	0.81	0.11	0.19

DE:LDBB	€4.64
GB:0ABR
GB:HLUNAC
AT:LUNA
DK:HLUN A	DKK33.55